The committee concluded that UroLift is clinically effective, with sustained relief of lower urinary tract symptoms up to 5 years after treatment. It is implanted using a minimally invasive procedure.

テレフレックスメディカルジャパン株式会社（本社：東京都新宿区、代表取締役社長：ナム・リー）は、国内で初めて、前立腺肥大症に伴う排尿障害に対する植込み型前立腺組織牽引システム「UroLift® システム」を2022年4月1日より発売いたしました。

A consultant urological, laparoscopic, and robotic surgeon, Professor Kingsley Ekwueme, has successfully performed West Africa's first UroLift procedure, a new minimally invasive treatment for ...

UroLift is a minimally invasive treatment for Benign Prostatic Hyperplasia, a condition that causes an enlarged prostate in men. The procedure uses tiny implants to lift and hold the enlarged prostate ...

NICE commissioned an external assessment centre (EAC) to review the evidence submitted by the company. This section summarises that review. Full details of all the evidence are in the project ...